Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jaka Biotech CoBJSE:920165 20 OCF Margin % is 34.64% as of Jun. 2026, which is 0% above its 10-year median of 34.62. GuruFocus rates BJSE:920165 with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 1,960 Consumer Packaged Goods companies, Jaka Biotech Co ranks better than 96.48% on this metric.
The historical rank and industry rank for Jaka Biotech Co's OCF Margin % or its related term are showing as below:
BJSE:920165'
s OCF Margin % Range Over the Past 10 Years
Min: 26.55 Med: 34.62 Max: 37.38
Current: 31.37
During the past 4 years, the highest OCF Margin % of Jaka Biotech Co was 37.38%. The lowest was 26.55%. And the median was 34.62%.
BJSE:920165's OCF Margin % is ranked better than 96.48% of 1960
companies
in the Consumer Packaged Goods industry
Industry Median: 6.405
vs BJSE:920165: 31.37
The historical data trend for Jaka Biotech Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BJSE:920165 vs PG, CL, EL: OCF Margin % Comparison
For the Household & Personal Products subindustry, Jaka Biotech Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jaka Biotech Co OCF Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Jaka Biotech Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Jaka Biotech Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jaka Biotech Co (BJSE:920165) has a OCF Margin % of 34.64% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Jaka Biotech Co and its competitors. This is near median its historical median of 34.62. Over the past decade, Jaka Biotech Co's OCF Margin % has ranged from 26.55 to 37.38. According to the industry distribution chart, Jaka Biotech Co ranks #69 out of 1960 companies in the Consumer Packaged Goods industry, placing it in the top 3.5%.
Is Jaka Biotech Co's OCF Margin % too high?
Jaka Biotech Co's current OCF Margin % of 34.64% is near median its 10-year median of 34.62. Over the past 10 years, this metric has ranged from a low of 26.55 to a high of 37.38. The Consumer Packaged Goods industry median OCF Margin % is 6.41. Jaka Biotech Co's value of 34.64% is 440.8% above this industry median. Based on the distribution chart, Jaka Biotech Co ranks #69 out of 1960 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Jaka Biotech Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Jaka Biotech Co's OCF Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Jaka Biotech Co ranks #69 out of 1960 companies for OCF Margin %. This places Jaka Biotech Co in the top 4% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 6.41. Jaka Biotech Co's value of 34.64% is 440.8% above this benchmark. Historically, Jaka Biotech Co's own OCF Margin % has ranged from 26.55 to 37.38 over the past decade. While the company's 10-year median is 34.62 vs. the industry median of 6.41, Jaka Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Consumer Packaged Goods company?
The median OCF Margin % among Consumer Packaged Goods companies is 6.41, based on 1,960 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jaka Biotech Co's current OCF Margin % of 34.64% is 440.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Jaka Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median OCF Margin % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jaka Biotech Co's current OCF Margin % is 34.64%, which is near median its own 10-year median of 34.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jaka Biotech Co stock overvalued right now?
Jaka Biotech Co (BJSE:920165) has a current OCF Margin % of 34.64%. The current OCF Margin % is 34.64%, which is near median its 10-year median of 34.62 and 440.8% above the Consumer Packaged Goods industry median of 6.41. Jaka Biotech Co's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Jaka Biotech Co (BJSE:920165), the current OCF Margin % is 34.64% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jaka Biotech Co Ltd is engaged in the research, development, production and sales of cosmetic functional ingredients. Its operations include pharmaceutical manufacturing, testing and inspection services, manufacturing and sales of specialty chemical products, and bio-based materials.
20GF Score
Get the complete analysis for BJSE:920165
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920165 has been successfully added to your 
